Frank D. Lee's Net Worth
$1.79 Million
Who is Frank D. Lee?
Frank D. Lee has an estimated net worth of $1.79 Million. This is based on reported shares across multiple companies, which include Forma Therapeutics Holdings, Inc.,, Bolt Biotherapeutics, Inc., Pacira BioSciences, Inc., and Bausch Health Companies Inc..
SEC CIK
Frank D. Lee's CIK is 0001814686
Past Insider Trading and Trends
2022 was Frank D. Lee's most active year for acquiring shares with 5 total transactions. Frank D. Lee's most active month to acquire stocks was the month of January. 2022 was Frank D. Lee's most active year for disposing of shares, totalling 8 transactions. Frank D. Lee's most active month to dispose stocks was the month of September. 2024 saw Frank D. Lee paying a total of $99,994.40 for 857,656 shares, this is the most they've acquired in one year. In 2022 Frank D. Lee cashed out on 2,146,153 shares for a total of $175,809.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Forma Therapeutics Holdings, Inc., No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -201.44K |
—
|
—
|
0
|
Oct 14
| |||
Form 4
| +152.52% | 121.67K |
—
|
—
| 201.44K |
Feb 28
| |||
Form 4
| -18.39% | -17.98K |
$9.78 | -$175,809.23 | 79.77K |
Feb 23
| |||
Form 4
|
∞
| 97.75K |
—
|
—
| 97.75K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $0.641
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira BioSciences, Inc. (PCRX) Snapshot price: $13.89
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.30% | 8.26K |
$12.10 | $99,994.40 | 107.78K |
Aug 12
| |||
Form 4
|
∞
| 99.52K |
—
|
—
| 99.52K |
Jan 2 - Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bausch Health Companies Inc. (BHC) Snapshot price: $6.1229
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 35.36K |
—
|
—
| 35.36K |
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||